CORDRAN SP Drug Patent Profile
✉ Email this page to a colleague
When do Cordran Sp patents expire, and when can generic versions of Cordran Sp launch?
Cordran Sp is a drug marketed by Almirall and is included in one NDA.
The generic ingredient in CORDRAN SP is flurandrenolide. There are four drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the flurandrenolide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cordran Sp
A generic version of CORDRAN SP was approved as flurandrenolide by PADAGIS ISRAEL on August 30th, 2016.
Summary for CORDRAN SP
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 50 |
Patent Applications: | 5,649 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CORDRAN SP at DailyMed |
Pharmacology for CORDRAN SP
Drug Class | Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
US Patents and Regulatory Information for CORDRAN SP
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Almirall | CORDRAN SP | flurandrenolide | CREAM;TOPICAL | 012806-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Almirall | CORDRAN SP | flurandrenolide | CREAM;TOPICAL | 012806-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |